ROTAVAC 5D
Phase 3Small molecule
ROTAVAC 5D is one of 3 small molecule programs targeting Rotavirus Vaccine. It is currently in Phase 3.
1
Indications
3
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Rotavirus Vaccine
#DrugCompanyPhaseTrials
1Rotarix ™
GSKPhase 3
ROTAVAC 5D
BBharat Biotech International Limited
Phase 3
Luminate
PfizerPhase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for ROTAVAC 5D. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details